Top

Published in:

Open Access 01-08-2018 | Original Article

Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases

Authors: Xuan Li, Ye Chen, Yunjia Tang, Yueyue Ding, Qiuqin Xu, Lin Sun, Weiguo Qian, Guanghui Qian, Liqiang Qin, Haitao Lv

Published in: European Journal of Pediatrics | Issue 8/2018

Abstract

The purpose of this study was to identify the clinical features and laboratory factors that are predictive of intravenous immunoglobulin (IVIG)-resistant Kawasaki disease. Multiple databases were searched for relevant studies on IVIG-resistant Kawasaki disease published from January 2002 to April 2017. Eligible studies were retrieved by manual review of the references. Stata 12 was used for the meta-analysis. Weighted mean differences and odds ratios with 95% confidence intervals were calculated for several indices. Twenty-eight studies involving 26,260 patients comprising 4442 IVIG-resistant Kawasaki disease patients and 21,818 IVIG-sensitive Kawasaki disease patients were included. The meta-analysis showed that the erythrocyte sedimentation rate (ESR) in the IVIG-resistant group was significantly higher than that in the IVIG-sensitive group, and that platelet count and hemoglobin levels were significantly lower in the IVIG-resistant group. The patients with oral mucosa alterations, cervical lymphadenopathy, swelling of the extremities, polymorphous rash, and initial administration of IVIG ≤ 4.0 days after the onset of symptoms were more likely to be IVIG resistant.

Conclusion: The initial administration of IVIG ≤ 4.0 days after the onset of symptoms increased ESR and decreased hemoglobin and platelet counts, oral mucosa alterations, cervical lymphadenopathy, swelling of the extremities, and polymorphous rash and are the risk factors for IVIG-resistant Kawasaki disease.

What is Known:

• Recent reports on this topic are about aspartate aminotransferase (AST), alanine aminotransferase (ALT), gammaglutamyl transferase, total bilirubin, white blood cells, platelets, erythrocyte sedimentation rate (ESR), polymorphonuclear leukocytes (PMN), C-reactive protein (CRP), pro-brain natriuretic peptide (BNP), albumin, and sodium as the risk factors in the IVIG-resistant Kawasaki disease; however, no studies have been published on clinical features as predictors of IVIG resistance.

What is New:

• This meta-analysis identified the clinical features, the initial administration of IVIG ≤ 4.0 days after the onset of symptoms, and much more comprehensive laboratory indicators, such as hemoglobin, as predictors of IVIG-resistant Kawasaki disease.

Available only for authorised users

Ashouri N, Takahashi M, Dorey F, Mason W (2008) Risk factors for nonresponse to therapy in Kawasaki disease. J Pediatr 153(3):365–368. https://doi.org/10.1016/j.jpeds.2008.03.014 CrossRefPubMed

Baek JY, Song MS (2016) Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. Korean J Pediatr 59(2):80–90. https://doi.org/10.3345/kjp.2016.59.2.80 CrossRefPubMedPubMedCentral

Campbell AJ, Burns JC (2016) Adjunctive therapies for Kawasaki disease. J Inf Secur 72(Suppl):S1–S5. https://doi.org/10.1016/j.jinf.2016.04.015 CrossRef

Cha S, Yoon M, Ahn Y, Han M, Yoon KL (2008) Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease. J Korean Med Sci 23(4):718–722. https://doi.org/10.3346/jkms.2008.23.4.718 CrossRefPubMedPubMedCentral

Chen S, Dong Y, Yin Y, Krucoff MW (2013) Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis. Heart 99(2):76–82. https://doi.org/10.1136/heartjnl-2012-302126 CrossRefPubMed

Choi MH, Park CS, Kim DS (2014) Prediction of intravenous immunoglobulin nonresponse Kawasaki disease in Korea. Korean Journal of Pediatric Infectious Diseases 21:29-36CrossRef

Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA (2015) Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child 100(4):366–368. https://doi.org/10.1136/archdischild-2014-307397 CrossRefPubMed

Del Principe D, Pietraforte D, Gambardella L, Marchesi A, Tarissi de Jacobis I, Villani A, Malorni W, Straface E (2017) Pathogenetic determinants in Kawasaki disease: the haematological point of view. J Cell Mol Med 21(4):632–639. https://doi.org/10.1111/jcmm.12992 CrossRefPubMedPubMedCentral

Du ZD, Zhang YL, Zhao D, Du JB, Lu S, Yi JM, et al (2006) Retreatment and risk factors of IVIG nonresponsiveness. Chinese Journal of Practical Pediatrics 21 (10):738-741

10.

Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24(2):145–148. https://doi.org/10.1007/s00246-002-0216-2 CrossRefPubMed

11.

Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149(2):237–240. https://doi.org/10.1016/j.jpeds.2006.03.050 CrossRefPubMed

12.

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefPubMedPubMedCentral

13.

Fu PP, Du ZD, Pan YS (2013) Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatr Infect Dis J 32(8):e319–e323. https://doi.org/10.1097/INF.0b013e31828e887f PubMedCrossRef

14.

Group JCSJW (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J 78(10):2521–2562CrossRef

15.

Hartas GA, Hashmi SS, Pham-Peyton C, Tsounias E, Bricker JT, Gupta-Malhotra M (2015) Immunoglobulin resistance in Kawasaki disease. Pediatr Allergy Immunol Pulmonol 28(1):13–19. https://doi.org/10.1089/ped.2014.0423 CrossRefPubMedPubMedCentral

16.

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. https://doi.org/10.1002/sim.1186 CrossRefPubMed

17.

Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D (2011) Assessment of intravenous immunoglobulin non-responders in Kawasaki disease. Arch Dis Child 96(11):1088–1090. https://doi.org/10.1136/adc.2010.184101 CrossRefPubMed

18.

Kim SY, Han MY, Cha SH, Jeon YB (2013) N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study. Pediatr Cardiol 34(8):1837–1843. https://doi.org/10.1007/s00246-013-0724-2 CrossRefPubMed

19.

Kim BY, Kim D, Kim YH, Ryoo E, Sun YH, Jeon IS, Jung MJ, Cho HK, Tchah H, Choi DY, Kim NY (2016) Non-responders to intravenous immunoglobulin and coronary artery dilatation in Kawasaki disease: predictive parameters in Korean children. Korean Circ J 46(4):542–549. https://doi.org/10.4070/kcj.2016.46.4.542 CrossRefPubMedPubMedCentral

20.

Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113(22):2606–2612. https://doi.org/10.1161/CIRCULATIONAHA.105.592865 CrossRefPubMed

21.

Kobayashi T, Inoue Y, Otani T, Morikawa A, Kobayashi T, Takeuchi K, Saji T, Sonobe T, Ogawa S, Miura M, Arakawa H (2009) Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease. Pediatr Infect Dis J 28(6):498–502CrossRefPubMed

22.

Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD (2010) Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr 99(10):1578–1583. https://doi.org/10.1111/j.1651-2227.2010.01875.x CrossRefPubMed

23.

Lee HY, Song MS (2016) Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease. Korean J Pediatr 59(12):477–482. https://doi.org/10.3345/kjp.2016.59.12.477 CrossRefPubMedPubMedCentral

24.

Lee SM, Lee JB, Go YB, Song HY, Lee BJ, Kwak JH (2014) Prediction of resistance to standard intravenous immunoglobulin therapy in Kawasaki disease. Korean Circ J 44(6):415–422. https://doi.org/10.4070/kcj.2014.44.6.415 CrossRefPubMedPubMedCentral

25.

Lin MT, Chang CH, Sun LC, Liu HM, Chang HW, Chen CA, Chiu SN, Lu CW, Chang LY, Wang JK, Wu MH (2016) Risk factors and derived Formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease. J Formos Med Assoc 115(5):350–355. https://doi.org/10.1016/j.jfma.2015.03.012 CrossRefPubMed

26.

Liu F, Ding Y, Yin W (2012) Clinical analysis of Kawasaki disease with non-responsiveness immunoglobulin therapy. J Appl Clin Pediatr 27(21):1670–1671

27.

Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E (2016) Role of the Egami score in predicting intravenous immunoglobulin resistance in Kawasaki disease among different ethnicities. Am J Ther 23(6):e1293–e1299. https://doi.org/10.1097/MJT.0000000000000045 CrossRefPubMed

28.

Muta H, Ishii M, Furui J, Nakamura Y, Matsuishi T (2006) Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 95(2):189–193. https://doi.org/10.1080/08035250500327328 CrossRefPubMed

29.

Nakagama Y, Inuzuka R, Hayashi T, Shindo T, Hirata Y, Shimizu N, Inatomi J, Yokoyama Y, Namai Y, Oda Y, Takamizawa M, Harita Y, Oka A (2016) Fever pattern and C-reactive protein predict response to rescue therapy in Kawasaki disease. Pediatr Int 58(3):180–184. https://doi.org/10.1111/ped.12762 CrossRefPubMed

30.

Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol 22(3):216–221CrossRefPubMedPubMedCentral

31.

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever E, Kawasaki Disease CoCDitYAHA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 114(6):1708–1733. https://doi.org/10.1542/peds.2004-2182 CrossRefPubMed

32.

Ou-Yang MC, Kuo HC, Lin IC, Sheen JM, Huang FC, Chen CC, Huang YH, Lin YJ, Yu HR (2013) Plasma clusterin concentrations may predict resistance to intravenous immunoglobulin in patients with Kawasaki disease. ScientificWorldJournal 2013:382523. https://doi.org/10.1155/2013/382523 CrossRefPubMedPubMedCentral

33.

Piao JH, Jin LH, Sun JH, Jin CJ, Zhai SB, Lv J (2009) Clinical analysis of Kawasaki disease patients with non-responsiveness to high-dose gammaglobulin therapy. Journal of Clinical Pediatrics 27(5):480-483

34.

Ram Krishna M, Sundaram B, Dhanalakshmi K (2014) Predictors of coronary artery aneurysms in Kawasaki disease. Clin Pediatr (Phila) 53(6):561–565. https://doi.org/10.1177/0009922814530802 CrossRef

35.

Rigante D, Valentini P, Rizzo D, Leo A, De Rosa G, Onesimo R, De Nisco A, Angelone DF, Compagnone A, Delogu AB (2010) Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int 30(6):841–846. https://doi.org/10.1007/s00296-009-1337-1 CrossRefPubMed

36.

Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166(2):131–137. https://doi.org/10.1007/s00431-006-0223-z CrossRefPubMed

37.

Sato S, Kawashima H, Kashiwagi Y, Hoshika A (2013) Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients. Int J Rheum Dis 16(2):168–172. https://doi.org/10.1111/1756-185X.12082 CrossRefPubMed

38.

Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, Atz AM, Printz BF, Baker A, Vetter VL, Newburger JW, Pediatric Heart Network I (2011) Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 158(5):831–835 e833. https://doi.org/10.1016/j.jpeds.2010.10.031 CrossRefPubMed

39.

Son MB, Newburger JW (2013) Kawasaki disease. Pediatr Rev 34(4):151–162CrossRefPubMed

40.

Straface E, Marchesi A, Gambardella L, Metere A, Tarissi de Jacobis I, Viora M, Giordani L, Villani A, Del Principe D, Malorni W, Pietraforte D (2012) Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease? Antioxid Redox Signal 17(10):1441–1446. https://doi.org/10.1089/ars.2012.4660 CrossRefPubMed

41.

Tang Y, Yan W, Sun L, Huang J, Qian W, Ding Y, Lv H (2016) Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population. Clin Rheumatol 35(11):2771–2776. https://doi.org/10.1007/s10067-016-3370-2 CrossRefPubMed

42.

Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, Martin DD, Newburger JW, Burns JC (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153(1):117–121. https://doi.org/10.1016/j.jpeds.2007.12.021 CrossRefPubMedPubMedCentral

43.

Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H (2008) Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J 27(2):155–160. https://doi.org/10.1097/INF.0b013e31815922b5 PubMedCrossRef

44.

Yan H, Wan H, Du JB, Chen YH, Li WZ, Liu XQ, Jin HF (2012) Risk factors and prediction analysis of intravenous immunoglobulin resistant Kawasaki disease. J Appl Clin Pediatr 27(21):1637–1640

45.

Yang TJ, Lin MT, Lu CY, Chen JM, Lee PI, Huang LM, Wu MH, Chang LY (2017) The prevention of coronary arterial abnormalities in Kawasaki disease: a meta-analysis of the corticosteroid effectiveness. J Microbiol Immunol Infect. https://doi.org/10.1016/j.jmii.2017.08.012

Title: Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases
Authors: Xuan Li
Ye Chen
Yunjia Tang
Yueyue Ding
Qiuqin Xu
Lin Sun
Weiguo Qian
Guanghui Qian
Liqiang Qin
Haitao Lv
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Pediatrics / Issue 8/2018
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-018-3182-2

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2018

Risk factors for periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: a case-control study

Influence of different delivery modes on the clinical characteristics of Chlamydia trachomatis pneumonia

A systematic review of clinical pharmacist interventions in paediatric hospital patients

Trends in paediatric inpatient antibiotic therapy in a secondary care setting

The impact of social inequalities on children’s knowledge and representation of health and cancer

First report on the nationwide incidence of type 1 diabetes and ketoacidosis at onset in children in Serbia: a multicenter study